Trimi vs LTTL: Pricing, shipping, verification compared
Quick verdict: For lower base pricing, consistent flat rates and free overnight shipping choose Trimi; for an up-to-$140 first-month promotion and independent lab verification choose LTTL.
Trimi vs LTTL begins with price and verification differences that matter most to shoppers comparing compounded GLP-1 options early in their research. Trimi advertises compounded semaglutide from $99/month on annual plans with flat pricing that never rises as dose increases and free overnight, temperature-controlled shipping; LTTL offers up to $140 off your first month with code auto-applied and positions its compounded GLP-1 as prepared by state-licensed pharmacies and independently verified in FDA registered labs.
Price and pricing model compared
Trimi lists semaglutide from $99/month and tirzepatide at $125/month on annual plans and emphasizes one flat membership price that stays the same as dose changes. LTTL lists pricing elements like $249 and $129 (4 doses/month) in captured details and promotes an offer of up to $140 off your first month with a code auto-applied. Trimi includes a stated 6-month money-back promise; LTTL’s captured details do not show a comparable refund promise.
Shipping, fulfillment, and medication preparation
Both providers rely on compounded medications and state-licensed pharmacies. Trimi highlights free overnight, temperature-controlled shipping and named compounding pharmacies with certificates of analysis available on request. LTTL notes medications are compounded by U.S.A. licensed pharmacies, prepared in state-licensed pharmacy settings, and delivered to your door when needed.
View LTTL delivery and compounding details
Verification, quality checks, and clinical review
Trimi states medications are compounded by state-licensed 503A pharmacies and mentions named pharmacies and an available certificate of analysis. Trimi also describes clinical oversight from licensed U.S. providers through Arora Health, led by a named medical director. LTTL captures that its preparation is independently verified in FDA registered labs and that strength is confirmed every 3–6 months to stay within plus or minus 10 percent of the target strength. LTTL also notes treatment is available only when a licensed clinician determines it is medically appropriate.
Refunds, eligibility, and medical oversight
Trimi advertises a 6-month money-back promise: follow your plan for 6 months and if you don’t lose weight you can request a refund, with terms applying. Trimi also advises confirming eligibility, medication, total cost, renewal terms and state availability before enrollment. LTTL’s captured materials advise confirming eligibility, medication, total cost, renewal terms and state availability before enrollment and indicate treatment availability depends on a licensed clinician’s determination. Both sources include the regulatory note that compounded medications are not FDA-approved and are not reviewed by FDA for safety, effectiveness or quality.
Check Trimi eligibility and refund terms
Distinctive differences at a glance
| Criteria | Trimi | LTTL |
|---|---|---|
| Starting price | $99/month (semaglutide on annual plan) | Captured elements include up to $140 off first month; price examples captured: $249, $129 |
| Pricing model | Flat pricing that never rises as dose increases; same price at every dose | Same price, every dose; first-month promotion available |
| Shipping | Free overnight, temperature-controlled shipping | Delivered to your door when you need it |
| Pharmacy verification | Compounded by state-licensed 503A pharmacies; named pharmacies and certificate of analysis available on request | Compounded by U.S. licensed pharmacies; independently verified in FDA registered labs |
| Strength confirmation | Not supplied in captured evidence | Confirmed every 3–6 months to stay within ± 10% of target strength |
| Refund / guarantee | 6-month money-back promise (terms apply) | No comparable refund promise captured |
See LTTL pricing and lab verification
How clinical oversight differs
Trimi describes licensed U.S. providers and medical oversight through Arora Health with a named board-certified physician leading the clinical network. LTTL indicates treatment is available when a licensed clinician determines it is medically appropriate but does not include the same named clinical leadership in the captured materials.
What neither source supplies
Neither captured source provides exhaustive current pricing tables across all plan tiers in the captured evidence, nor does either provider’s captured summary replace a full eligibility or state-availability check. Both remind users that compounded medications are not FDA-approved and are not reviewed by FDA for safety, effectiveness or quality.
Conclusion: Trimi vs LTTL — which to choose
Trimi vs LTTL comes down to priorities. If your priority is lower advertised starting price on an annual plan, flat per-dose pricing that does not increase with dose, named compounding pharmacies and a stated 6-month money-back promise, Trimi matches those points. If your priority is an initial promotional reduction and independent lab verification with routine strength confirmation every 3–6 months, LTTL emphasizes those checks and an up-to-$140 first-month offer.
Choose Trimi if you want a lower starting price on the captured annual plan, flat pricing that never rises as dose increases, free overnight shipping and a 6-month money-back promise. Choose LTTL if you value an applied first-month promotion and independent verification in FDA registered labs with routine strength confirmation.